How long does it usually take to know if my biologic treatment is working for Crohn’s or ulcerative colitis?

For most people with Crohn’s disease or ulcerative colitis, it takes around 8 to 12 weeks on a biologic before we can judge response reliably. Doctors look at symptoms, blood or stool markers, and sometimes endoscopy results over this period to decide if the treatment is helping.

Can the gut microbiome help predict biologic treatment success in Crohn’s and ulcerative colitis?

Early research, including a review in BMJ Open Gastroenterology, suggests that people who eventually respond well to biologics often show early changes in their gut microbiome within the first 2 to 4 weeks. These shifts include a move towards more helpful, anti-inflammatory bacteria and a more balanced microbiome. This is promising, but it is not yet a routine clinical tool.

Can I currently choose a biologic based on microbiome testing?

At the moment, we cannot choose a biologic treatment solely based on microbiome testing. Biologics are still selected using clinical factors such as disease pattern, severity, past treatments and overall health. Microbiome research is an exciting future direction, but not a standalone decision tool today.

What can I do today to support my long-term success on biologic treatment?

While biologics remain the backbone of treatment, the gut microbiome clearly plays an important role in overall gut health. You cannot yet use the microbiome to choose a biologic, but you can start focusing on supporting your gut microbiome now, alongside your medical treatment, as part of long-term IBD care.

Predicting Biologic Treatment Success in Crohn’s & UC | UK-trained Gastroenterologist in Dubai

By Dr Pranab Gyawali, Consultant Gastroenterologist
Published: 29 November 2025

If you’re living with Crohn’s disease or ulcerative colitis, one of the most important questions you might have—whether here in Dubai or anywhere else—is:

“How do we know if this biologic treatment will work for me?”

For many years, the decision-making process has been remarkably consistent. We look at your disease pattern, the severity of inflammation, what you’ve tried before, and clinical judgement. Then we start a biologic, and we usually wait 8–12 weeks to see how your body responds.

But new research suggests there may be a way to understand treatment success much earlier—and this is what I focus on in this VLOG.

Why Patients Ask About Biologic Treatment Success

Many patients I see search for or ask things like:

“How long until my biologic starts working?”
“Why is my biologic not working?”
“Can we predict if I will respond?”
“Is there a better way to choose a biologic?”

This uncertainty is completely understandable, especially for people who have tried more than one biologic or have had mixed results.

Predicting biologic treatment success is a major focus in inflammatory bowel disease (IBD) research right now. Some of the findings are genuinely interesting and may help shape future care.

What the Latest Research Shows

A recent review in BMJ Open Gastroenterology highlighted a pattern seen across several studies:

Patients who eventually respond well to biologics often show early changes in their gut microbiome—sometimes within just 2–4 weeks.

These early microbial changes can include:

a small rise in helpful, anti-inflammatory bacteria,
a reduction in bacteria associated with inflammation,
an early shift toward a more “balanced” microbiome.

What’s notable is that these changes often appear before symptoms start improving, offering a potential early signal that the biologic is working.

Reference:
BMJ Open Gastroenterology (2024)
https://bmjopengastro.bmj.com/content/11/2/e001482

Does This Apply to All Biologics?

The studies reviewed included people using several commonly prescribed biologics for Crohn’s disease and ulcerative colitis, such as:

infliximab,
adalimumab,
vedolizumab,
ustekinumab,
and newer IL-23–specific biologics.

The idea here is not about choosing “the best” biologic. Instead, it focuses on recognising early patterns—particularly in the gut microbiome—that might predict response to whichever biologic has been selected for your situation.

Can We Use the Microbiome to Choose Biologics Today?

Not yet. This is promising science, but it is still early.

At the moment, we cannot select biologic treatment based on microbiome testing alone, and we cannot rely on these early microbial markers in isolation. Biologics are still chosen using established clinical factors: disease pattern, severity, previous treatments and your overall health profile.

However, the direction is encouraging. In time, research like this may help us:

identify responders earlier,
make faster decisions for non-responders,
develop more personalised IBD treatment pathways,
and integrate microbiome data alongside other biomarkers.

For patients here in Dubai and elsewhere, that could make biologic treatment more predictable and more tailored to the individual.

What Can I Do Today?

While biologics remain the backbone of treatment for Crohn’s and ulcerative colitis, it’s becoming increasingly clear that the microbiome also plays an important role in overall gut health.

We cannot yet use the microbiome to choose or predict biologic response in day-to-day practice, but there is something meaningful you can work on today: supporting your gut microbiome.

This is an area I discuss often across my pages and VLOGs, because looking after your microbiome is one part of long-term IBD care that you can start focusing on right now, alongside your prescribed treatment—regardless of which biologic you are on.

You’ll find more about this in the pages and VLOGs linked below.

Predicting Biologic Treatment Success in Crohn’s & Ulcerative Colitis — Insights From a UK-Trained Gastroenterologist in Dubai

REQUEST AN APPOINTMENT

Dr. Gyawali is exclusively available at

Mubadala Health – Jumeirah, Dubai

Menu Links

PATIENT REVIEWS